Overview
Support Groups
Latest News
Events
Clinical Trials
Avian influenza
Search Trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years
Status:
Completed
Last Changed:
Jul 9, 2018
First Changed:
Jul 21, 2008
Disease(s):
Influenza
Intervention(s):
A/turkey H5N1 vaccineInfluenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)Placebo
Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59
Status:
Completed
Last Changed:
Jul 14, 2020
First Changed:
Apr 13, 2018
Disease(s):
Influenza A Virus, H5N1 Subtype
Intervention(s):
VNINdk/BANGgf/WAbhg/QLAS03 adjuvantMF59 adjuvant
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults
Status:
Completed
Last Changed:
Sep 21, 2018
First Changed:
Aug 15, 2011
Disease(s):
Influenza
Intervention(s):
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Status:
Completed
Last Changed:
Nov 1, 2021
First Changed:
Mar 8, 2011
Disease(s):
Influenza
Intervention(s):
Influenza A (H5N1) Virus monovalent vaccineSaline placebo
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Status:
Completed
Last Changed:
Aug 31, 2020
First Changed:
Feb 11, 2016
Disease(s):
A/Vietnam/H5N1 Influenza Virus
Intervention(s):
7.5 mcg H5N1 (stored as monobulk)15 mcg H5N1 (stored as monobulk)90 mcg H5N1 (stored as monobulk)90 mcg H5N1 (stored in vials)MF59MF59 (stored as monobulk)
